drugset / Trial / NCT01155999
Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
RandomizedParallel-groupSingle-blindTreatment
Summary
Efficacy/Safety of T1225, in comparison to reference product, for the treatment of purulent bacterial conjunctivitis of children.
Timeline
- Start
- 2008-12
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | T1225 | Unknown | — | Topical |
| Comparator | Tobramycin | Small molecule | 0.3 % | Topical |